Extension of Time to File SOU

GERON

Geron Corporation

Request for Extension of Time to File a Statement of Use

PTO- 1581
Approved for use through 12/31/2020. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88757457
LAW OFFICE ASSIGNED LAW OFFICE 109
MARK SECTION
MARK GERON (see, http://uspto.report/TM/88757457/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT GERON
OWNER SECTION (current)
NAME Geron Corporation
MAILING ADDRESS 919 E. Hillsdale Blvd., Suite 250
CITY Foster City
STATE California
ZIP/POSTAL CODE 94404
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
OWNER SECTION (proposed)
NAME Geron Corporation
MAILING ADDRESS 919 E. Hillsdale Blvd., Suite 250
CITY Foster City
STATE California
ZIP/POSTAL CODE 94404
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME Rochelle D. Alpert
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE rochelle.alpert@morganlewis.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) sftrademarks@morganlewis.com
CORRESPONDENCE INFORMATION (proposed)
NAME Rochelle D. Alpert
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE rochelle.alpert@morganlewis.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) sftrademarks@morganlewis.com
DOCKET/REFERENCE NUMBER 058901.2200
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Therapeutic, diagnostic, and prophylactic preparations, pharmaceutical products and agents for the treatment, diagnosis or prophylaxis of human diseases, disorders and conditions, namely, cancers and hematologic diseases, syndromes and disorders
GOODS OR SERVICES KEEP ALL LISTED
INTERNATIONAL CLASS 035
CURRENT IDENTIFICATION Promoting collaboration within the scientific, research and provider communities to achieve advances in the fields of treatment, diagnosis and prophylaxis of cancers and hematologic diseases, syndromes and disorders
GOODS OR SERVICES KEEP ALL LISTED
INTERNATIONAL CLASS 042
CURRENT IDENTIFICATION Providing medical information in the field of the diagnosis and treatment of cancers and hematologic malignancies to consumers, and providing medical information in the field of prevention, screening, diagnosis and treatment to scientists, researchers and medical providers on cancers and hematologic diseases, syndromes and disorders
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 1
ALLOWANCE MAIL DATE 07/21/2020
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 3
SUBTOTAL AMOUNT [EXTENSION FEE] 375
TOTAL AMOUNT 375
SIGNATURE SECTION
SIGNATURE /rda/
SIGNATORY'S NAME Rochelle D. Alpert
SIGNATORY'S POSITION Attorney of Record for Applicant, CA State Bar
DATE SIGNED 01/19/2021
SIGNATORY'S PHONE NUMBER 415 442-1326
SIGNATURE METHOD Signed directly within the form
FILING INFORMATION
SUBMIT DATE Tue Jan 19 20:27:58 ET 2021
TEAS STAMP USPTO/ESU-XXX.XXX.XXX.XX-
20210119202758251012-8875
7457-7603584fbccd3c16bc0a
21d99dc985f8c2272fe359a4f
5a9edd9af52c4c2da2ff-DA-2
7563656-20210119202510975
108



PTO- 1581
Approved for use through 12/31/2020. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: GERON (see, http://uspto.report/TM/88757457/mark.png)
SERIAL NUMBER: 88757457

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Geron Corporation, having an address of
      919 E. Hillsdale Blvd., Suite 250
      Foster City, California 94404
      United States
      Email: XXXX
Proposed: Geron Corporation, having an address of
      919 E. Hillsdale Blvd., Suite 250
      Foster City, California 94404
      United States
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 07/21/2020.

For International Class 005:
Current identification: Therapeutic, diagnostic, and prophylactic preparations, pharmaceutical products and agents for the treatment, diagnosis or prophylaxis of human diseases, disorders and conditions, namely, cancers and hematologic diseases, syndromes and disorders

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 035:
Current identification: Promoting collaboration within the scientific, research and provider communities to achieve advances in the fields of treatment, diagnosis and prophylaxis of cancers and hematologic diseases, syndromes and disorders

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 042:
Current identification: Providing medical information in the field of the diagnosis and treatment of cancers and hematologic malignancies to consumers, and providing medical information in the field of prevention, screening, diagnosis and treatment to scientists, researchers and medical providers on cancers and hematologic diseases, syndromes and disorders

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the first extension request.

Correspondence Information (current):
      Rochelle D. Alpert
      PRIMARY EMAIL FOR CORRESPONDENCE: rochelle.alpert@morganlewis.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): sftrademarks@morganlewis.com

Correspondence Information (proposed):
      Rochelle D. Alpert
      PRIMARY EMAIL FOR CORRESPONDENCE: rochelle.alpert@morganlewis.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): sftrademarks@morganlewis.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $375 will be submitted with the form, representing payment for 3 classes.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /rda/      Date Signed: 01/19/2021
Signatory's Name: Rochelle D. Alpert
Signatory's Position: Attorney of Record for Applicant, CA State Bar
Signatory's Phone: 415 442-1326
Signature method: Signed directly within the form

PAYMENT: 88757457
PAYMENT DATE: 01/19/2021

Serial Number: 88757457
Internet Transmission Date: Tue Jan 19 20:27:58 ET 2021
TEAS Stamp: USPTO/ESU-XXX.XXX.XXX.XX-202101192027582
51012-88757457-7603584fbccd3c16bc0a21d99
dc985f8c2272fe359a4f5a9edd9af52c4c2da2ff
-DA-27563656-20210119202510975108




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed